{"id":"NCT00833911","sponsor":"Labopharm Inc.","briefTitle":"An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee","officialTitle":"An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-04","primaryCompletion":"2004-07","completion":"2004-07","firstPosted":"2009-02-02","resultsPosted":"2009-06-02","lastUpdate":"2012-04-30"},"enrollment":392,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee"],"interventions":[{"type":"DRUG","name":"Tramadol Once A Day","otherNames":[]}],"arms":[{"label":"Tramadol ContramidÂ® OAD","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to collect information regarding the long-term (6 and 12 months) safety of Tramadol HCl Once-A-Day(OAD) 300 mg.","primaryOutcome":{"measure":"Number of Patients Having Experienced an Adverse Event During the 6-12 Month Open-Label Safety Participation","timeFrame":"6 months and 12 months","effectByArm":[{"arm":"All Patients With 1 Dose of 300 mg Tramadol HCl OAD Minimum","deltaMin":346,"sd":null},{"arm":"6-months Safety","deltaMin":188,"sd":null},{"arm":"12-months Safety","deltaMin":121,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["18052769"],"seeAlso":["http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9048"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":392},"commonTop":["Nausea","Constipation","Dizziness","Somnolence","Headache"]}}